Requirement of transforming growth factor ?–activated kinase 1 for transforming growth factor ?–induced -smooth muscle actin expression and extracellular matrix contraction in fibroblasts

Shi-Wen , Xu and Parapuram, Sunil K. and Pala , Daphne and Chen, Yunliang and Carter , David E. and Eastwood, Mark and Denton, Christopher P. and Abraham, David J. and Leask, Andrew (2009) Requirement of transforming growth factor ?–activated kinase 1 for transforming growth factor ?–induced -smooth muscle actin expression and extracellular matrix contraction in fibroblasts. Arthritis & Rheumatism, 60 (1). pp. 234-241. ISSN 0004-3591

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1002/art.24223

Abstract

Objective - Fibrosis is believed to occur through normal tissue remodeling failing to terminate. Tissue repair intimately involves the ability of fibroblasts to contract extracellular matrix (ECM), and enhanced ECM contraction is a hallmark of fibrotic cells in various conditions, including scleroderma. Some fibrogenic transcriptional responses to transforming growth factor ? (TGF?), including -smooth muscle actin (-SMA) expression and ECM contraction, require focal adhesion kinase/Src (FAK/Src). The present study was undertaken to assess whether TGF?-activated kinase 1 (TAK1) acts downstream of FAK/Src to mediate fibrogenic responses in fibroblasts. Methods - We used microarray, real-time polymerase chain reaction, Western blot, and collagen gel contraction assays to assess the ability of wild-type and TAK1-knockout fibroblasts to respond to TGF?1. Results - The ability of TGF to induce TAK1 was blocked by the FAK/Src inhibitor PP2. JNK phosphorylation in response to TGF?1 was impaired in the absence of TAK1. TGF? could not induce matrix contraction or expression of a group of fibrotic genes, including -SMA, in the absence of TAK1. Conclusion - These results suggest that TAK1 operates downstream of FAK/Src in mediating fibrogenic responses and that targeting of TAK1 may be a viable antifibrotic strategy in the treatment of certain disorders, including scleroderma.

Item Type: Article
Subjects: University of Westminster > Science and Technology > Life Sciences, School of (No longer in use)
Depositing User: Miss Nina Watts
Date Deposited: 14 Apr 2011 10:53
Last Modified: 14 Apr 2011 10:53
URI: http://westminsterresearch.wmin.ac.uk/id/eprint/9311

Actions (login required)

Edit Item (Repository staff only) Edit Item (Repository staff only)